Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

Peter Rossing; Justus G Garweg; Stefan D Anker; Takeshi Osonoi; Bertram Pitt; Sylvia E Rosas; Luis Miguel Ruilope; Dalong Zhu; Meike Brinker; David Finis; Sergio Leal; Thomas Schmelter; George Bakris

doi:10.1111/dom.14915

Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

Peter Rossing, Justus G Garweg, Stefan D Anker, Takeshi Osonoi, Bertram Pitt, Sylvia E Rosas, Luis Miguel Ruilope, Dalong Zhu, Meike Brinker, David Finis, Sergio Leal, Thomas Schmelter, George Bakris

Steno Diabetes Center Copenhagen

14 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Diabetes, Obesity and Metabolism
Vol/bind	25
Udgave nummer	3
Sider (fra-til)	894-898
Antal sider	5
ISSN	1462-8902
DOI	https://doi.org/10.1111/dom.14915
Status	Udgivet - mar. 2023

Adgang til dokumentet

10.1111/dom.14915

Andre filer og links

Link to publication in Scopus

Citationsformater

Rossing, P., Garweg, J. G., Anker, S. D., Osonoi, T., Pitt, B., Rosas, S. E., Ruilope, L. M., Zhu, D., Brinker, M., Finis, D., Leal, S., Schmelter, T., & Bakris, G. (2023). Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR). Diabetes, Obesity and Metabolism, 25(3), 894-898. https://doi.org/10.1111/dom.14915

Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR). / Rossing, Peter; Garweg, Justus G; Anker, Stefan D et al.
I: Diabetes, Obesity and Metabolism, Bind 25, Nr. 3, 03.2023, s. 894-898.

Publikation: Bidrag til tidsskrift › Leder › peer review

Rossing, P, Garweg, JG, Anker, SD, Osonoi, T, Pitt, B, Rosas, SE, Ruilope, LM, Zhu, D, Brinker, M, Finis, D, Leal, S, Schmelter, T & Bakris, G 2023, 'Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)', Diabetes, Obesity and Metabolism, bind 25, nr. 3, s. 894-898. https://doi.org/10.1111/dom.14915

Rossing P, Garweg JG, Anker SD, Osonoi T, Pitt B, Rosas SE et al. Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR). Diabetes, Obesity and Metabolism. 2023 mar.;25(3):894-898. Epub 2022 nov. 4. doi: 10.1111/dom.14915

Rossing, Peter ; Garweg, Justus G ; Anker, Stefan D et al. / Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy : Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR). I: Diabetes, Obesity and Metabolism. 2023 ; Bind 25, Nr. 3. s. 894-898.

@article{4c5e955b0de64e6c9f5b475465758e30,

title = "Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)",

keywords = "diabetic retinopathy, phase III study, randomized trial, type 2 diabetes",

author = "Peter Rossing and Garweg, {Justus G} and Anker, {Stefan D} and Takeshi Osonoi and Bertram Pitt and Rosas, {Sylvia E} and Ruilope, {Luis Miguel} and Dalong Zhu and Meike Brinker and David Finis and Sergio Leal and Thomas Schmelter and George Bakris",

year = "2023",

month = mar,

doi = "10.1111/dom.14915",

language = "English",

volume = "25",

pages = "894--898",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy

T2 - Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

AU - Rossing, Peter

AU - Garweg, Justus G

AU - Anker, Stefan D

AU - Osonoi, Takeshi

AU - Pitt, Bertram

AU - Rosas, Sylvia E

AU - Ruilope, Luis Miguel

AU - Zhu, Dalong

AU - Brinker, Meike

AU - Finis, David

AU - Leal, Sergio

AU - Schmelter, Thomas

AU - Bakris, George

PY - 2023/3

Y1 - 2023/3

KW - diabetic retinopathy

KW - phase III study

KW - randomized trial

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85142871509&partnerID=8YFLogxK

U2 - 10.1111/dom.14915

DO - 10.1111/dom.14915

M3 - Editorial

C2 - 36331803

SN - 1462-8902

VL - 25

SP - 894

EP - 898

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 3

ER -